DCF — HOUSTON MEDICAL CENTER
Enterprise Value: $-419.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-419.6M
Enterprise Value
$-131.7M
PV of Cash Flows
$-287.8M
PV of Terminal Value
$-463.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $233.2M | $-26.7M | -11.0% | $-36.5M | $-33.2M |
| Year 2 | $240.2M | $-25.1M | -10.0% | $-35.2M | $-29.1M |
| Year 3 | $247.4M | $-23.4M | -9.0% | $-33.8M | $-25.4M |
| Year 4 | $254.8M | $-22.8M | -9.0% | $-33.6M | $-22.9M |
| Year 5 | $262.5M | $-22.8M | -9.0% | $-33.9M | $-21.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-419.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$226.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.11938296015822493
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5